IBEC Seminar: Thomas Graf
Mechanisms of transcription factor induced transdifferentiation and reprogramming to pluripotency
Mechanisms of transcription factor induced transdifferentiation and reprogramming to pluripotency
Mechanisms of transcription factor induced transdifferentiation and reprogramming to pluripotency
Els propers dies 8, 9,10 i 11 d’abril, en el marc de la 13a edició de la Fira «Recerca en directe», investigadors de diversos centres de recerca de Catalunya … Read more
Els propers dies 8, 9,10 i 11 d’abril, en el marc de la 13a edició de la Fira «Recerca en directe», investigadors de diversos centres de recerca de Catalunya … Read more
Pioneering international study supported by the Obra Social “la Caixa” opens new possibilities to control metastasisAt a press conference at the Obra Social “la Caixa”’s Palau Macaya earlier today, Xavier Trepat, group leader at the Institute for Bioengineering of Catalonia (IBEC), Enric Banda, director of the department of Science and Environment of the Obra Social ”la Caixa”, and Josep Samitier, director of IBEC, described a study published in Nature Cell Biology which sheds new light on how to control metastasis.
An article and interview with Josep Samitier in El Mundo presents EIT Health and the Spanish node.
As Spain’s expert in optogenetics and optopharmacology, IBEC group leader Pau Gorostiza will be the star of the next “Diálogos por la Ciencia” event in Madrid next week.An initiative of the Fundación “la Caixa”, “Diálogos por la Ciencia” are a new way of communicating science to the public, in which prestigious scientists with international recognition are interviewed live in front of a audience of the public by a renowned journalist.
ICREA research professor Pau, who heads IBEC’s Nanoprobes and Nanoswitches group, will talk about his work developing light-controlled drugs at the event in Madrid on 25th March.
The increasing prevalence of bacteria that are resistant to current antibiotics pose an escalating threat to human health. Now, researchers in Barcelona have identified a molecule with huge potential as a new type of antibacterial agentAccess to effective antibiotics is essential in all health systems. Their use has reduced childhood mortality and increased life expectancy, and they are crucial for invasive surgery and treatments such as cancer chemotherapy and organ transplants.
IBEC research was highlighted in the morning news on Telecinco today when new group leader Samuel Sánchez’s nanorobots were presented as a potential future substitute for chemotherapy.